Alp N - Search Results

1

Duration of action of antispasmodic agents: novel use of a mouse model as an in vivo pharmacological assay.

Mussa S, Prior T, Alp N, Wood K, Channon KM, Taggart DP. Mussa S, et al. Among authors: alp n. Eur J Cardiothorac Surg. 2004 Nov;26(5):988-94. doi: 10.1016/j.ejcts.2004.06.018. Eur J Cardiothorac Surg. 2004. PMID: 15519194

2

Endothelial nitric oxide synthase dysfunction in diabetic mice: importance of tetrahydrobiopterin in eNOS dimerisation.

Cai S, Khoo J, Mussa S, Alp NJ, Channon KM. Cai S, et al. Among authors: alp nj. Diabetologia. 2005 Sep;48(9):1933-40. doi: 10.1007/s00125-005-1857-5. Epub 2005 Jul 21. Diabetologia. 2005. PMID: 16034613

3

Increased intimal hyperplasia in experimental vein graft stenting compared to arterial stenting: comparisons in a new rabbit model of stent injury.

Alp NJ, West NE, Arnold N, Gunn J, Banning AP, Channon KM. Alp NJ, et al. Cardiovasc Res. 2002 Oct;56(1):164-72. doi: 10.1016/s0008-6363(02)00503-5. Cardiovasc Res. 2002. PMID: 12237177

4

Increased in-stent stenosis in ApoE knockout mice: insights from a novel mouse model of balloon angioplasty and stenting.

Ali ZA, Alp NJ, Lupton H, Arnold N, Bannister T, Hu Y, Mussa S, Wheatcroft M, Greaves DR, Gunn J, Channon KM. Ali ZA, et al. Among authors: alp nj. Arterioscler Thromb Vasc Biol. 2007 Apr;27(4):833-40. doi: 10.1161/01.ATV.0000257135.39571.5b. Epub 2007 Jan 4. Arterioscler Thromb Vasc Biol. 2007. PMID: 17204666

5

Severe endothelial dysfunction in the aorta of a mouse model of Fabry disease; partial prevention by N-butyldeoxynojirimycin treatment.

Heare T, Alp NJ, Priestman DA, Kulkarni AB, Qasba P, Butters TD, Dwek RA, Clarke K, Channon KM, Platt FM. Heare T, et al. Among authors: alp nj. J Inherit Metab Dis. 2007 Feb;30(1):79-87. doi: 10.1007/s10545-006-0473-y. Epub 2006 Dec 25. J Inherit Metab Dis. 2007. PMID: 17189993

6

Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease.

Alp NJ, Channon KM. Alp NJ, et al. Arterioscler Thromb Vasc Biol. 2004 Mar;24(3):413-20. doi: 10.1161/01.ATV.0000110785.96039.f6. Epub 2003 Dec 4. Arterioscler Thromb Vasc Biol. 2004. PMID: 14656731 Review.

7

Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice.

Alp NJ, McAteer MA, Khoo J, Choudhury RP, Channon KM. Alp NJ, et al. Arterioscler Thromb Vasc Biol. 2004 Mar;24(3):445-50. doi: 10.1161/01.ATV.0000115637.48689.77. Epub 2004 Jan 5. Arterioscler Thromb Vasc Biol. 2004. PMID: 14707037

8

EPR quantification of vascular nitric oxide production in genetically modified mouse models.

Khoo JP, Alp NJ, Bendall JK, Kawashima S, Yokoyama M, Zhang YH, Casadei B, Channon KM. Khoo JP, et al. Nitric Oxide. 2004 May;10(3):156-61. doi: 10.1016/j.niox.2004.04.003. Nitric Oxide. 2004. PMID: 15158695

9

Functional comparison of the endothelial nitric oxide synthase Glu298Asp polymorphic variants in human endothelial cells.

McDonald DM, Alp NJ, Channon KM. McDonald DM, et al. Pharmacogenetics. 2004 Dec;14(12):831-9. doi: 10.1097/00008571-200412000-00006. Pharmacogenetics. 2004. PMID: 15608562

10

Congenic mapping and genotyping of the tetrahydrobiopterin-deficient hph-1 mouse.

Khoo JP, Nicoli T, Alp NJ, Fullerton J, Flint J, Channon KM. Khoo JP, et al. Mol Genet Metab. 2004 Jul;82(3):251-4. doi: 10.1016/j.ymgme.2004.04.006. Mol Genet Metab. 2004. PMID: 15234340

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters